Keppra (levetiracetam) has been approved for adjunctive treatment of partial-onset seizures with or without secondary generalisation in children from 1 month of age. It was previously licensed for this indication only in children over 6 months.
The starting dose in children aged 1-6 months is 7mg/kg oral solution twice daily.
Further information: UCB
To sign up for the MIMS monthly news update, register at www.mims.co.uk/bulletins.